Back
Bel Fuse Vs. Keros Therapeutics Industry Stock Comparison
Buy
83
BELFB
Bel Fuse
Last Price:
$102.28
Seasonality Move:
7.35%
Sell
31
KROS
Keros Therapeutics
Last Price:
$14.33
Seasonality Move:
9.82%
Sell
31
Keros Therapeutics (KROS)
is a Sell
Is Keros Therapeutics a Buy, Sell or Hold?
-
The current Keros Therapeutics [KROS] share price is $14.32. The Score for KROS is 31, which is 38% below its historic median score of 50, and infers higher risk than normal.
-
KROS is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
BELFB Stock Price Chart
KROS Stock Price Chart
What is Keros Therapeutics's stock price today?
-
The Keros Therapeutics share price today is $14.32Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and KROS is experiencing slight buying pressure.
BELFB Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 6.07 | Buy |
Relative Strength Index (14 RSI): | 77.25 | Buy |
Chaikin Money Flow: | 46336 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (80.18 - 98.1) | Buy |
Bollinger Bands (100): | (68.88 - 87.34) | Buy |
KROS Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 2 | Buy |
Relative Strength Index (14 RSI): | 61.59 | Buy |
Chaikin Money Flow: | 27829 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (13.31 - 14.39) | Buy |
Bollinger Bands (100): | (11.17 - 14.33) | Buy |
BELFB Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 98.87 | Buy |
20-day SMA: | 92.65 | Buy |
50-day SMA: | 80.93 | Buy |
200-day SMA: | 79.18 | Buy |
8-day EMA: | 98.69 | Buy |
20-day EMA: | 92.9 | Buy |
50-day EMA: | 84.86 | Buy |
200-day EMA: | 77.29 | Buy |
KROS Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 13.58 | Buy |
20-day SMA: | 13.61 | Buy |
50-day SMA: | 14 | Buy |
200-day SMA: | 26.96 | Sell |
8-day EMA: | 5.59 | Buy |
20-day EMA: | 2.56 | Buy |
50-day EMA: | 1.09 | Buy |
200-day EMA: | 0.28 | Buy |
Bel Fuse Earnings Growth & BELFB Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.61 per share, an increase next quarter of $0.12 per share, an increase this year of $0.85 per share, and an increase next year of $0.72 per share.
Keros Therapeutics Earnings Growth & KROS Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.24 per share, a decrease next quarter of $0.03 per share, an increase this year of $4.50 per share, and a decrease next year of $4.46 per share.
Bel Fuse Technical Analysis
Jun 25 | Jun 26 | Jun 27 | Jun 30 | Jul 1 | Jul 2 | Jul 3 | Jul 7 | Jul 8 | Jul 9 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | Jul | |||||||||
25 | 26 | 27 | 30 | 01 | 02 | 03 | 07 | 08 | 09 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Keros Therapeutics Technical Analysis
Jun 25 | Jun 26 | Jun 27 | Jun 30 | Jul 1 | Jul 2 | Jul 3 | Jul 7 | Jul 8 | Jul 9 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | Jul | |||||||||
25 | 26 | 27 | 30 | 01 | 02 | 03 | 07 | 08 | 09 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |